Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
The fund will take equity positions in India-focused healthcare and life sciences-related companies
These courses are for pre-selected candidates who have completed their MBBS with an additional 2 years of surgical experience training
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
Data published in the prestigious journal ACS Central Science of the American Chemical Society
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Over the next three years, BASF will continue to support Beyond Suncare by supplying the required raw materials free of charge and by providing technical expertise to further improve the formulation
The investment will accelerate the overall Sarclisa development program
It is only the second generic application approved by the USFDA
First and only once-weekly patch for convenient, well-tolerated delivery of most used drug for the treatment of Alzheimer's-related dementia
Subscribe To Our Newsletter & Stay Updated
